Search results
Askel Healthcare to Present First Clinical Trial Results of Its COPLA® Knee Cartilage Implant at...
WWTI Watertown· 12 hours agoThe primary endpoint of the trial, safety, was successfully met in all initial ten patients. The...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 7 hours agoTo be executed through the clinical studies network of the Biomedical Advanced Research and...
Clario secures FDA 510(k) clearance for SpiroSphere with wireless ECG
Medical Device Network via Yahoo Finance· 7 hours agoOriginally launched in 2018 as a pulmonary function testing device, the SpiroSphere now boasts the...
LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial
Clinical Trials Arena via Yahoo Finance· 9 hours agoII LB-LR1109 dose. It will also assess the drug’s safety, initial efficacy, tolerability,...
Vertex says Casgevy benefit extends to nearly five years in sickle cell disease
Clinical Trials Arena via Yahoo Finance· 3 hours agoCLIMB-111 and CLIMB-121, are designed to assess the safety and efficacy of a single dose of Casgevy...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 9 hours agoModerna has announced that its Phase III clinical trial of the investigational next-generation...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 16 hours agoGLP-1 drugs like tirzepatide are large, complex molecules. Some early efforts at other drugmakers to...
Lixte Biotechnology inks deal for cancer drug trial By Investing.com
Investing.com· 3 hours agoLixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) has entered into a significant agreement with the...
Kymera reports promising Phase 1 results for KT-333 cancer drug By Investing.com
Investing.com· 4 hours agoThe data, shared at the European Hematology...malignancies, including complete responses in two...
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology...
Digital Journal· 6 hours agoTUS Monotherapy and TUS+Venetoclax (VEN) Doublet Therapy Show Broad Clinical Activity and Strong Safety Data in relapsed or refractory (R/R) Acute Myeloid ...